Tenaya Therapeutics Inc.

0.95
-0.06 (-5.94%)
At close: Mar 03, 2025, 3:59 PM
0.69
-27.30%
After-hours: Mar 03, 2025, 04:39 PM EST

Tenaya Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19
Net Income -124.08M -123.67M -72.72M -38.4M -26.23M
Depreciation & Amortization 8.69M 6.47M 2.96M 2.48M 1.99M
Stock-Based Compensation 15.31M 11.47M 2.95M 741K 414K
Other Working Capital -2.37M -2.51M -3.86M -376K -647K
Other Non-Cash Items 3.66M 2.16M 1.06M -75K 64K
Deferred Income Tax n/a n/a 192K 33K -82K
Change in Working Capital -5.65M -849K 4.74M -234K -250K
Operating Cash Flow -102.07M -104.42M -60.81M -35.45M -24.1M
Capital Expenditures -1.24M -20.63M -25.12M -9.76M -2.93M
Acquisitions n/a n/a n/a n/a 2.66K
Purchase of Investments -56.64M -140.48M -213.44M n/a -12.66M
Sales Maturities Of Investments 106.62M 244.75M n/a 2.75M 10M
Other Investing Acitivies -25K 8K -213.44K 2.75K -2.66K
Investing Cash Flow 48.72M 83.65M -238.56M -7.01M -5.58M
Debt Repayment n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a -13K -1K -3K
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 181K 380K 20.44M 147.27M 30.51M
Financial Cash Flow 4.05M 77.77M 208.97M 147.27M 30.51M
Net Cash Flow -49.31M 56.99M -90.41M 104.81M 832K
Free Cash Flow -103.31M -125.05M -85.93M -45.21M -27.02M